Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232238 | PMC |
http://dx.doi.org/10.1161/STROKEAHA.122.039534 | DOI Listing |
Mult Scler Relat Disord
December 2024
University of Miami Miller School of Medicine, Miami, FL, United States.
Background: Multiple sclerosis (MS) is a complex neurodegenerative disease characterized by immune dysregulation, affecting over 2.5 million people worldwide. Interestingly, COVID-19 infection can cause neurodegeneration through demyelination similar to that of MS, and COVID-19 infection can lead to long-term neurological sequelae, post-COVID-19 neurological syndrome.
View Article and Find Full Text PDFIndian J Psychol Med
January 2024
Dept. of Psychiatry, ESI-PGIMSR, ESIC Medical College and Hospital and Occupational Disease Center, Kolkata, West Bengal, India.
Limited literature exists regarding specific pharmacological treatments for COVID-19-associated brain fog (BF) syndrome. One previous study using bupropion lacked objectivity. In this multiple baseline case series study, methylphenidate was used in treating post-COVID BF syndrome.
View Article and Find Full Text PDFAppl Neuropsychol Adult
November 2024
College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
The term "brain fog" has emerged from the observations of neuropsychiatric conditions present in post-COVID-19 infections. This is characterized by concentration and memory problems, selective attention disorders and difficulties in executive functions, yet it is unclear how long these deficits may persist and which cognitive functions are most vulnerable. Therefore, there is a need to properly evaluate these cognitive complaints using an assessment tool that specifies their intensity and nature.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!